These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 99923)

  • 1. [Method of obtaining crystalline choleragen and choleragenoid preparations].
    Efremenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):45-9. PubMed ID: 99923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of highly purified choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Infect Dis; 1970 May; 121():Suppl 121:63+. PubMed ID: 4987011
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Exp Med; 1969 Jul; 130(1):185-202. PubMed ID: 4978880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystalline cholera toxin and toxoid.
    Finkelstein RA; LoSpalluto JJ
    Science; 1972 Feb; 175(4021):529-30. PubMed ID: 5008591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of cholera exo-enterotoxin (choleragen) to natural toxoid (choleragenoid).
    Finkelstein RA; Peterson JW; Lospalluto JJ
    J Immunol; 1971 Mar; 106(3):868-71. PubMed ID: 4993866
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).
    Finkelstein RA; Boesman M; Neoh SH; LaRue MK; Delaney R
    J Immunol; 1974 Jul; 113(1):145-50. PubMed ID: 4208916
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of cholera exo-enterotoxin (choleragen) and its natural toxoid (choleragenoid).
    Finkelstein RA
    Toxicon; 1972 Aug; 10(5):441-50. PubMed ID: 5071597
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of gamma radiation on the immunobiological and immunochemical properties of cholera exotoxin. IV. The biological and immunochemical properties of purified irradiated choleragen].
    Nedugova GI; Rubtsov IV; Samoĭlenko II
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Sep; (9):90-3. PubMed ID: 6438968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of Vibrio cholerae virulence: purification of cholera enterotoxin by preparative disc electrophoresis.
    Lewis AC; Richardson SH; Sheridan B
    Appl Environ Microbiol; 1976 Aug; 32(2):288-93. PubMed ID: 987751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1977 Jun; 16(3):789-95. PubMed ID: 892899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size and structure of the cholera toxin molecule and its subunits.
    Ohtomo N; Muraoka T; Tashiro A; Zinnaka Y; Amako K
    J Infect Dis; 1976 Mar; 133 Suppl():31-40. PubMed ID: 815449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.
    Bennett V; Mong L; Cuatrecasas P
    J Membr Biol; 1975 Nov; 24(2):107-29. PubMed ID: 172636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of permeability factor-cholera enterotoxin from complex and synthetic media.
    Richardson SH; Noftle KA
    J Infect Dis; 1970 May; 121():Suppl 121:73+. PubMed ID: 4987012
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of mitogen stimulation of human peripheral blood leukocytes by Vibrio cholerae enterotoxin.
    Hart DA; Finkelstein RA
    J Immunol; 1975 Jan; 114(1 Pt 2):476-80. PubMed ID: 123258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
    Honda T; Finkelstein RA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2052-6. PubMed ID: 109838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. I. Purification of enterotoxin C2.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):148-58. PubMed ID: 237564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possibilities of immunization against cholera and related enterotoxic enteropathies.
    Finkelstein RA
    Dev Biol Stand; 1976; 33():102-7. PubMed ID: 955264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible binding of vibrio cholerae toxin on NAD-sepharose.
    Antoni G; Brizzi A; Casagli MC; Neri P
    Ital J Biochem; 1978; 27(6):373-7. PubMed ID: 226497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of the exo-enterotoxin of Vibrio cholerae strain 110 Cal.
    Chukwumah EI; Akinwande AI; Akinrimisi EO; Odugbemi T
    West Afr J Med; 1995; 14(1):1-5. PubMed ID: 7626525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.